Precision medicine: Beyond newborn screening
Revity, Inc. was established in May 2023 as a science-based company that leverages innovation in life sciences and diagnostics to improve lives globally. Revvity Omics has replaced PerkinElmer Genomics as the company’s genomics services business. The organization builds on its legacy of screening 40 million babies annually across 110 countries for life-threatening diseases and leverages